Skip to main navigation Skip to search Skip to main content

Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series

  • Celia Morton
  • , Annette Lista
  • , Nicholas Jakowenko
  • , Eric Salazar
  • , Kevin R. Donahue

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science